Haemonetics Corporation (HAE)
Days of inventory on hand (DOH)
Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|
Inventory turnover | 3.71 | 3.95 | 3.20 | 2.65 | 3.61 | |
DOH | days | 98.50 | 92.41 | 114.08 | 137.80 | 101.06 |
March 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 3.71
= 98.50
The days of inventory on hand (DOH) for Haemonetics Corporation have shown varying trends over the past five years.
In fiscal year 2024, the DOH decreased to 98.50 days from 92.41 days in fiscal year 2023, indicating a more efficient management of inventory. This could suggest better inventory control and potentially faster inventory turnover.
The DOH was higher in fiscal year 2022 at 114.08 days compared to prior years, which may indicate slower inventory turnover or potential issues with inventory management during that period.
Furthermore, in fiscal year 2021, the DOH was even higher at 137.80 days, signifying an increase in the number of days it took to sell the inventory, possibly due to overstocking or a decline in demand.
The DOH decreased in fiscal year 2020 to 101.06 days, showing an improvement from the prior year. This could suggest efforts to streamline inventory processes or better demand forecasting.
Overall, a lower DOH indicates better inventory management and efficiency, while a higher DOH may signal potential issues such as excess inventory or slow sales. Tracking changes in the DOH can provide insights into the company's operational performance and supply chain management.
Peer comparison
Mar 31, 2024